Committee for Herbal Medicinal Products
E25179
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
All labels observed (3)
| Label | Occurrences |
|---|---|
| Committee for Herbal Medicinal Products canonical | 1 |
| Committee on Herbal Medicinal Products | 1 |
| Working Party on Herbal Medicinal Products | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T184506 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Committee for Herbal Medicinal Products Context triple: [European Medicines Agency, hasCommittee, Committee for Herbal Medicinal Products]
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
C.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
-
D.
Committee for Medicinal Products for Veterinary Use
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
-
E.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Committee for Herbal Medicinal Products Target entity description: The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
C.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
-
D.
Committee for Medicinal Products for Veterinary Use
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
-
E.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
European Union body
ⓘ
regulatory committee ⓘ scientific committee ⓘ |
| abbreviation | HMPC ⓘ |
| aim |
ensure high level of public health protection regarding herbal medicines
ⓘ
promote safe and effective use of herbal medicinal products in the EU ⓘ |
| composition |
experts nominated by EU Member States
ⓘ
members from EEA-EFTA states ⓘ patient and healthcare professional representatives ⓘ |
| country | European Union ⓘ |
| field |
herbal medicinal products
ⓘ
pharmacovigilance of herbal medicines ⓘ regulation of herbal medicines ⓘ |
| focusesOn |
traditional herbal medicinal products
ⓘ
well‑established use herbal medicinal products ⓘ |
| headquartersLocation |
Amsterdam
ⓘ
Netherlands ⓘ |
| inception | 2004 ⓘ |
| jurisdiction | European Union ⓘ |
| language | English ⓘ |
| mandate |
provide scientific basis for traditional use registrations
ⓘ
support authorisation of herbal medicinal products in EU Member States ⓘ |
| meetsAt | European Medicines Agency premises ⓘ |
| parentOrganization | European Medicines Agency ⓘ |
| partOf | European Medicines Agency ⓘ |
| produces |
EU herbal monographs
ⓘ
EU list entries for herbal substances ⓘ guidelines on efficacy of herbal medicinal products ⓘ guidelines on quality of herbal medicinal products ⓘ guidelines on safety of herbal medicinal products ⓘ |
| replaced |
Committee for Herbal Medicinal Products
self-linksurface differs
ⓘ
surface form:
Working Party on Herbal Medicinal Products
|
| role |
advise on traditional herbal medicinal products
ⓘ
assess benefit–risk balance of herbal medicinal products ⓘ assess quality of herbal medicinal products ⓘ develop guidance on herbal medicinal products ⓘ evaluate efficacy of herbal medicinal products ⓘ evaluate safety of herbal medicinal products ⓘ prepare community herbal monographs ⓘ prepare lists of herbal substances and preparations ⓘ provide scientific opinions on herbal medicinal products ⓘ support harmonisation of herbal medicine regulation in the EU ⓘ |
| subjectOf | European Union pharmaceutical legislation ⓘ |
| website | https://www.ema.europa.eu/en/committees/committee-herbal-medicinal-products-hmpc ⓘ |
| worksOnRegulatoryProcedure |
centralised procedure
ⓘ
decentralised procedure ⓘ mutual recognition procedure ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Committee for Herbal Medicinal Products Description of subject: The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.